Insights into the epidemiology, natural history and pathogenesis of hepatitis C virus infection from studies of infected donors and blood product recipients

被引:67
作者
Busch, MP
机构
[1] Blood Ctr Pacific, San Francisco, CA 94118 USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Blood Syst Inc, Scottsdale, AZ USA
关键词
hepatitis C virus; HCV blood donor; blood transfusion; pathogenesis;
D O I
10.1016/S1246-7820(01)00125-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Studies of patients with post-transfusion non-A, non-B hepatitis and their implicated donors were critical to the discovery of hepatitis C virus (HCV) and to the development and progressive enhancement of HCV immunoassays for donor screening and diagnostic applications. Post-transfusion HCV cases have also been used to define the time course of viral and immunological markers following acute infection. Even more precise data on the timing and characteristics of viremia and immune responses during primary HCV infection have been derived from studies of serial samples from source plasma donors who were identified while in the process of infection and seroconversion. Such data have been critical to the derivation of estimates for the viremic, pre-seroconversion window period, and hence projections of the yield of addition of nucleic acid amplification technology (NAT) or HCV core antigen enzyme immunoassays (Ag-ElAs) to antibody screening in donor and diagnostic settings. In addition to these implications for screening and diagnosis, studies of HCV in the blood donor and blood product recipient settings have yielded substantial insights into the epidemiology, pathogenesis and prognosis of HCV infection. In the future, prospective studies of blood and plasma donors detected in the primary phase of HCV infection by NAT screening, will be important for defining viral and host genetic and immunological determinants of clearance of acute viremia, as well as for investigating the benefits of early treatment. Thus, the findings from studies of HCV among donors and blood product recipients have yielded and should continue to provide important insights into HCV pathogenesis leading to novel diagnostic, therapeutic and vaccinaton strategies. (C) 2001 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:200 / 206
页数:7
相关论文
共 46 条
  • [41] CLASSIFICATION OF HEPATITIS-C VIRUS INTO 6 MAJOR GENOTYPES AND A SERIES OF SUBTYPES BY PHYLOGENETIC ANALYSIS OF THE NS-5 REGION
    SIMMONDS, P
    HOLMES, EC
    CHA, TA
    CHAN, SW
    MCOMISH, F
    IRVINE, B
    BEALL, E
    YAP, PL
    KOLBERG, J
    URDEA, MS
    [J]. JOURNAL OF GENERAL VIROLOGY, 1993, 74 : 2391 - 2399
  • [42] NAT of the United States and Canadian blood supply
    Stramer, SL
    Caglioti, S
    Strong, DM
    [J]. TRANSFUSION, 2000, 40 (10) : 1165 - 1168
  • [43] The natural history of hepatitis C virus infection - Host, viral, and environmental factors
    Thomas, DL
    Astemborski, J
    Rai, RM
    Anania, FA
    Schaeffer, M
    Galai, N
    Nolt, K
    Nelson, KE
    Strathdee, SA
    Johnson, L
    Laeyendecker, O
    Boitnott, J
    Wilson, LE
    Vlahov, D
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (04): : 450 - 456
  • [44] Tsai SL, 1997, HEPATOLOGY, V25, P449
  • [45] Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection
    Villano, SA
    Vlahov, D
    Nelson, KE
    Cohn, S
    Thomas, DL
    [J]. HEPATOLOGY, 1999, 29 (03) : 908 - 914
  • [46] WANG B, 2001, IN PRESS TRANSFUSION